Trial intelligence / Profile preview

Flixotide Effect on Allergen Response in Smoking Asthmatics

NCT01400906Phase 2Completed

Sponsor
GSK
Start
Jul 2011
Primary completion
Dec 2012
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of fluticasone propionate in asthma, sponsored by GSK. Started Jul 2011; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01400906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01400906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call